Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Lenalidomide Drug Market Growth 2022-2028

  • LP 4871439
  • 74 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Lenalidomide Drug will have significant change from previous year. According to our (LP Information) latest study, the global Lenalidomide Drug market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Lenalidomide Drug market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Lenalidomide Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Lenalidomide Drug market, reaching US$ million by the year 2028. As for the Europe Lenalidomide Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Lenalidomide Drug players cover Celgene, Exova, , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Lenalidomide Drug market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

5 mg Capsules

10 mg Capsules

15 mg Capsules

25 mg Capsules

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Multiple myeloma (MM)

Myelodysplastic syndromes (MDS)

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Celgene

Exova

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Lenalidomide Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Lenalidomide Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Lenalidomide Drug by Country/Region, 2017, 2022 & 2028

2.2 Lenalidomide Drug Segment by Type

2.2.1 5 mg Capsules

2.2.2 10 mg Capsules

2.2.3 15 mg Capsules

2.2.4 25 mg Capsules

2.3 Lenalidomide Drug Sales by Type

2.3.1 Global Lenalidomide Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Lenalidomide Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Lenalidomide Drug Sale Price by Type (2017-2022)

2.4 Lenalidomide Drug Segment by Application

2.4.1 Multiple myeloma (MM)

2.4.2 Myelodysplastic syndromes (MDS)

2.4.3 Other

2.5 Lenalidomide Drug Sales by Application

2.5.1 Global Lenalidomide Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Lenalidomide Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Lenalidomide Drug Sale Price by Application (2017-2022)

3 Global Lenalidomide Drug by Company

3.1 Global Lenalidomide Drug Breakdown Data by Company

3.1.1 Global Lenalidomide Drug Annual Sales by Company (2020-2022)

3.1.2 Global Lenalidomide Drug Sales Market Share by Company (2020-2022)

3.2 Global Lenalidomide Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Lenalidomide Drug Revenue by Company (2020-2022)

3.2.2 Global Lenalidomide Drug Revenue Market Share by Company (2020-2022)

3.3 Global Lenalidomide Drug Sale Price by Company

3.4 Key Manufacturers Lenalidomide Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Lenalidomide Drug Product Location Distribution

3.4.2 Players Lenalidomide Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Lenalidomide Drug by Geographic Region

4.1 World Historic Lenalidomide Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Lenalidomide Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Lenalidomide Drug Annual Revenue by Geographic Region

4.2 World Historic Lenalidomide Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Lenalidomide Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Lenalidomide Drug Annual Revenue by Country/Region

4.3 Americas Lenalidomide Drug Sales Growth

4.4 APAC Lenalidomide Drug Sales Growth

4.5 Europe Lenalidomide Drug Sales Growth

4.6 Middle East & Africa Lenalidomide Drug Sales Growth

5 Americas

5.1 Americas Lenalidomide Drug Sales by Country

5.1.1 Americas Lenalidomide Drug Sales by Country (2017-2022)

5.1.2 Americas Lenalidomide Drug Revenue by Country (2017-2022)

5.2 Americas Lenalidomide Drug Sales by Type

5.3 Americas Lenalidomide Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Lenalidomide Drug Sales by Region

6.1.1 APAC Lenalidomide Drug Sales by Region (2017-2022)

6.1.2 APAC Lenalidomide Drug Revenue by Region (2017-2022)

6.2 APAC Lenalidomide Drug Sales by Type

6.3 APAC Lenalidomide Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Lenalidomide Drug by Country

7.1.1 Europe Lenalidomide Drug Sales by Country (2017-2022)

7.1.2 Europe Lenalidomide Drug Revenue by Country (2017-2022)

7.2 Europe Lenalidomide Drug Sales by Type

7.3 Europe Lenalidomide Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Lenalidomide Drug by Country

8.1.1 Middle East & Africa Lenalidomide Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Lenalidomide Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Lenalidomide Drug Sales by Type

8.3 Middle East & Africa Lenalidomide Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Lenalidomide Drug

10.3 Manufacturing Process Analysis of Lenalidomide Drug

10.4 Industry Chain Structure of Lenalidomide Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Lenalidomide Drug Distributors

11.3 Lenalidomide Drug Customer

12 World Forecast Review for Lenalidomide Drug by Geographic Region

12.1 Global Lenalidomide Drug Market Size Forecast by Region

12.1.1 Global Lenalidomide Drug Forecast by Region (2023-2028)

12.1.2 Global Lenalidomide Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Lenalidomide Drug Forecast by Type

12.7 Global Lenalidomide Drug Forecast by Application

13 Key Players Analysis

13.1 Celgene

13.1.1 Celgene Company Information

13.1.2 Celgene Lenalidomide Drug Product Offered

13.1.3 Celgene Lenalidomide Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Celgene Main Business Overview

13.1.5 Celgene Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Lenalidomide Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Lenalidomide Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 5 mg Capsules

Table 4. Major Players of 10 mg Capsules

Table 5. Major Players of 15 mg Capsules

Table 6. Major Players of 25 mg Capsules

Table 7. Global Lenalidomide Drug Sales by Type (2017-2022) & (K Units)

Table 8. Global Lenalidomide Drug Sales Market Share by Type (2017-2022)

Table 9. Global Lenalidomide Drug Revenue by Type (2017-2022) & ($ million)

Table 10. Global Lenalidomide Drug Revenue Market Share by Type (2017-2022)

Table 11. Global Lenalidomide Drug Sale Price by Type (2017-2022) & (USD/Unit)

Table 12. Global Lenalidomide Drug Sales by Application (2017-2022) & (K Units)

Table 13. Global Lenalidomide Drug Sales Market Share by Application (2017-2022)

Table 14. Global Lenalidomide Drug Revenue by Application (2017-2022)

Table 15. Global Lenalidomide Drug Revenue Market Share by Application (2017-2022)

Table 16. Global Lenalidomide Drug Sale Price by Application (2017-2022) & (USD/Unit)

Table 17. Global Lenalidomide Drug Sales by Company (2020-2022) & (K Units)

Table 18. Global Lenalidomide Drug Sales Market Share by Company (2020-2022)

Table 19. Global Lenalidomide Drug Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Lenalidomide Drug Revenue Market Share by Company (2020-2022)

Table 21. Global Lenalidomide Drug Sale Price by Company (2020-2022) & (USD/Unit)

Table 22. Key Manufacturers Lenalidomide Drug Producing Area Distribution and Sales Area

Table 23. Players Lenalidomide Drug Products Offered

Table 24. Lenalidomide Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Lenalidomide Drug Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Lenalidomide Drug Sales Market Share Geographic Region (2017-2022)

Table 29. Global Lenalidomide Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Lenalidomide Drug Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Lenalidomide Drug Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Lenalidomide Drug Sales Market Share by Country/Region (2017-2022)

Table 33. Global Lenalidomide Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Lenalidomide Drug Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Lenalidomide Drug Sales by Country (2017-2022) & (K Units)

Table 36. Americas Lenalidomide Drug Sales Market Share by Country (2017-2022)

Table 37. Americas Lenalidomide Drug Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Lenalidomide Drug Revenue Market Share by Country (2017-2022)

Table 39. Americas Lenalidomide Drug Sales by Type (2017-2022) & (K Units)

Table 40. Americas Lenalidomide Drug Sales Market Share by Type (2017-2022)

Table 41. Americas Lenalidomide Drug Sales by Application (2017-2022) & (K Units)

Table 42. Americas Lenalidomide Drug Sales Market Share by Application (2017-2022)

Table 43. APAC Lenalidomide Drug Sales by Region (2017-2022) & (K Units)

Table 44. APAC Lenalidomide Drug Sales Market Share by Region (2017-2022)

Table 45. APAC Lenalidomide Drug Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Lenalidomide Drug Revenue Market Share by Region (2017-2022)

Table 47. APAC Lenalidomide Drug Sales by Type (2017-2022) & (K Units)

Table 48. APAC Lenalidomide Drug Sales Market Share by Type (2017-2022)

Table 49. APAC Lenalidomide Drug Sales by Application (2017-2022) & (K Units)

Table 50. APAC Lenalidomide Drug Sales Market Share by Application (2017-2022)

Table 51. Europe Lenalidomide Drug Sales by Country (2017-2022) & (K Units)

Table 52. Europe Lenalidomide Drug Sales Market Share by Country (2017-2022)

Table 53. Europe Lenalidomide Drug Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Lenalidomide Drug Revenue Market Share by Country (2017-2022)

Table 55. Europe Lenalidomide Drug Sales by Type (2017-2022) & (K Units)

Table 56. Europe Lenalidomide Drug Sales Market Share by Type (2017-2022)

Table 57. Europe Lenalidomide Drug Sales by Application (2017-2022) & (K Units)

Table 58. Europe Lenalidomide Drug Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Lenalidomide Drug Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Lenalidomide Drug Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Lenalidomide Drug Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Lenalidomide Drug Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Lenalidomide Drug Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Lenalidomide Drug Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Lenalidomide Drug Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Lenalidomide Drug Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Lenalidomide Drug

Table 68. Key Market Challenges & Risks of Lenalidomide Drug

Table 69. Key Industry Trends of Lenalidomide Drug

Table 70. Lenalidomide Drug Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Lenalidomide Drug Distributors List

Table 73. Lenalidomide Drug Customer List

Table 74. Global Lenalidomide Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Lenalidomide Drug Sales Market Forecast by Region

Table 76. Global Lenalidomide Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Lenalidomide Drug Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Lenalidomide Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Lenalidomide Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Lenalidomide Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Lenalidomide Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Lenalidomide Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Lenalidomide Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Lenalidomide Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Lenalidomide Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Lenalidomide Drug Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Lenalidomide Drug Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Lenalidomide Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Lenalidomide Drug Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Lenalidomide Drug Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Lenalidomide Drug Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Lenalidomide Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Lenalidomide Drug Revenue Market Share Forecast by Application (2023-2028)

Table 94. Celgene Basic Information, Lenalidomide Drug Manufacturing Base, Sales Area and Its Competitors

Table 95. Celgene Lenalidomide Drug Product Offered

Table 96. Celgene Lenalidomide Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 97. Celgene Main Business

Table 98. Celgene Latest Developments

Table 99. Exova Basic Information, Lenalidomide Drug Manufacturing Base, Sales Area and Its Competitors

Table 100. Exova Lenalidomide Drug Product Offered

Table 101. Exova Lenalidomide Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 102. Exova Main Business

Table 103. Exova Latest Developments

List of Figures

Figure 1. Picture of Lenalidomide Drug

Figure 2. Lenalidomide Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Lenalidomide Drug Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Lenalidomide Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Lenalidomide Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 5 mg Capsules

Figure 10. Product Picture of 10 mg Capsules

Figure 11. Product Picture of 15 mg Capsules

Figure 12. Product Picture of 25 mg Capsules

Figure 13. Global Lenalidomide Drug Sales Market Share by Type in 2021

Figure 14. Global Lenalidomide Drug Revenue Market Share by Type (2017-2022)

Figure 15. Lenalidomide Drug Consumed in Multiple myeloma (MM)

Figure 16. Global Lenalidomide Drug Market: Multiple myeloma (MM) (2017-2022) & (K Units)

Figure 17. Lenalidomide Drug Consumed in Myelodysplastic syndromes (MDS)

Figure 18. Global Lenalidomide Drug Market: Myelodysplastic syndromes (MDS) (2017-2022) & (K Units)

Figure 19. Lenalidomide Drug Consumed in Other

Figure 20. Global Lenalidomide Drug Market: Other (2017-2022) & (K Units)

Figure 21. Global Lenalidomide Drug Sales Market Share by Application (2017-2022)

Figure 22. Global Lenalidomide Drug Revenue Market Share by Application in 2021

Figure 23. Lenalidomide Drug Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Lenalidomide Drug Revenue Market Share by Company in 2021

Figure 25. Global Lenalidomide Drug Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Lenalidomide Drug Revenue Market Share by Geographic Region in 2021

Figure 27. Global Lenalidomide Drug Sales Market Share by Region (2017-2022)

Figure 28. Global Lenalidomide Drug Revenue Market Share by Country/Region in 2021

Figure 29. Americas Lenalidomide Drug Sales 2017-2022 (K Units)

Figure 30. Americas Lenalidomide Drug Revenue 2017-2022 ($ Millions)

Figure 31. APAC Lenalidomide Drug Sales 2017-2022 (K Units)

Figure 32. APAC Lenalidomide Drug Revenue 2017-2022 ($ Millions)

Figure 33. Europe Lenalidomide Drug Sales 2017-2022 (K Units)

Figure 34. Europe Lenalidomide Drug Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Lenalidomide Drug Sales 2017-2022 (K Units)

Figure 36. Middle East & Africa Lenalidomide Drug Revenue 2017-2022 ($ Millions)

Figure 37. Americas Lenalidomide Drug Sales Market Share by Country in 2021

Figure 38. Americas Lenalidomide Drug Revenue Market Share by Country in 2021

Figure 39. United States Lenalidomide Drug Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Lenalidomide Drug Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Lenalidomide Drug Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Lenalidomide Drug Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Lenalidomide Drug Sales Market Share by Region in 2021

Figure 44. APAC Lenalidomide Drug Revenue Market Share by Regions in 2021

Figure 45. China Lenalidomide Drug Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Lenalidomide Drug Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Lenalidomide Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Lenalidomide Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Lenalidomide Drug Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Lenalidomide Drug Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Lenalidomide Drug Sales Market Share by Country in 2021

Figure 52. Europe Lenalidomide Drug Revenue Market Share by Country in 2021

Figure 53. Germany Lenalidomide Drug Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Lenalidomide Drug Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Lenalidomide Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Lenalidomide Drug Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Lenalidomide Drug Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Lenalidomide Drug Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Lenalidomide Drug Revenue Market Share by Country in 2021

Figure 60. Egypt Lenalidomide Drug Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Lenalidomide Drug Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Lenalidomide Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Lenalidomide Drug Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Lenalidomide Drug Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Lenalidomide Drug in 2021

Figure 66. Manufacturing Process Analysis of Lenalidomide Drug

Figure 67. Industry Chain Structure of Lenalidomide Drug

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390